Middle East & Africa Organoids Market Forecast to 2030

Middle East & Africa Organoids Market Forecast to 2030 – Regional Analysis – by Organ Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Development of Biology Disease, Pathology of infectious Disease, Regenerative Medicines, Drug Discovery and Personalized Medicine, Drug Toxicity and Efficacy Testing, and Others), Source (Pluripotent Stem Cell and Organ Specific Adult Stem Cell), and Type (Instruments, Consumables, and Services)

Send Enquiry
Item ID: TIPRE00018855 Category: Tags: , ,

$2,485$3,885

Description

The Middle East & Africa organoids market is expected to grow from US$ 66.44 million in 2022 to US$ 245.34 million by 2030. It is estimated to grow at a CAGR of 17.7% from 2022 to 2030.

Combining Organoid with Organ-On-A-Chip Fuel the Middle East & Africa Organoids Market

Organoid and organ-on-a-chip, which serve as evolving pathological and human physiological relevant in vitro models, have the potential to revolutionize the conventional paradigm of cancer research and produce real clinical benefits. The recent inclination in the collaborative application of organoids with organ-on-a-chip and 3D bioprinting enables the development of sophisticated cancer models to study underlying mechanisms of tumor-stroma interactions, multiorgan tumor metastasis, and cancer-microenvironment interactions. By incorporating multiple organoids into organ-on-a-chip, organoid-on-a-chip can inherit benefits of both organoid and organ-on-a-chip and provide a valuable tool to study multiorgan tumor metastases and cancer-microenvironment interactions.

In addition, technological advancements will facilitate various applications in biological and biomedical fields for disease modeling and clinical drug screening by combining organoids with organ-on-a-chip. Technological advancements have enabled the development of brain organoids-on-chip, liver organoids-on-chip, intestine organoids-on-chip, and more. Although organoid-on-a-chip is currently a developing field, much scope exists for improvement. Thus, it will also require cooperative efforts from interdisciplinary researchers to reach organoids’ full utility in human biomedical studies and lead the market’s growth in the coming future.

Middle East & Africa Organoids Market Overview

The Middle East & Africa organoids market is segmented into UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. The regional growth is attributed to growing research on cancer and gene mutations, increasing disease modeling, and developments by market players offering organoids. Factors such as developing healthcare facilities, organizing conferences and meetings to share key facts associated with stem cell technologies, and increasing partnerships with foreign entities are likely to further propel the market growth during 2022-2030.

Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Organoids Market Segmentation

The Middle East & Africa organoids market is segmented into organ type, type, application, source, and country.

Based on organ type, the Middle East & Africa organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the Middle East & Africa organoids market in 2022.

Based on type, the Middle East & Africa organoids market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the North America organoid market in 2022.

Based on application, the Middle East & Africa organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held largest share of the Middle East & Africa organoids market in 2022.

Based on source, the Middle East & Africa organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held a larger share of the Middle East & Africa organoids market in 2022.

Based on country, the Middle East & Africa organoids market is segmented int o the South Africa, Saudi Arabia, UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa organoids market in 2022.

Cellesce, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Middle East & Africa organoids market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 17.7% CAGR, the Middle East & Africa Organoids Market is speculated to be worth US$ 245.34 million by 2030, saysthe research team

According tothe research team’ research, the Middle East & Africa Organoids market was valued at US$ 66.44 million in 2022 and is expected to reach US$ 245.34 million by 2030, registering a CAGR of 17.7% from 2022 to 2030. Increasing demand for tumor modeling and biobanking and growing adoption of personalized drugs are the critical factors attributed to the Middle East & Africa Organoids market expansion.

Organoids are microscopic and self-organizing 3D structures grown from stem cells in vitro. They review various structural and functional characteristics of their in vivo counterpart organs. This multipurpose technology has led to several novel human cancer models. It is now possible to create indefinitely expanding organoids starting from the tumor tissue of individuals suffering from a range of carcinomas. Alternatively, CRISPR-based gene modification allows the engineering of organoid models of cancer by introducing any combination of cancer gene alterations to normal organoids. Tumor organoids, when combined with immune cells and fibroblasts, become a model for the cancer microenvironment enabling immune-oncology applications. Also, recent studies have proved that organoids have a place in personalized medicine approaches.

The constant progress in organoid technology has paved the way for tumors and patient-centric 3D cultures of cells isolated from tumor biopsies. Over the past few decades, organoids have been generated from diverse human cancers associated with breast, colon, pancreas, prostate, bladder, and liver. Studies involving these models help in providing key facts about these malignancies. Due to constant advancements in the current scenario, tumoroid lines are increasingly being passed in vitro, opening new paths for a range of downstream applications. Moreover, 3D-based cultures offer added advantages over conventional 2D cancer-derived cell lines. Further, recent research and development activities have specified that tumoroid culturing is highly effective in allowing the collection of various cancer subtypes from a large pool of patients. As organoids can be easily derived and expanded from single cancer cells, the adoption of organoids to mimic intratumor diversification in culture is increasing, which, in turn, is propelling the Middle East & Africa organoids market.

Companies have been developing innovative biobanks for storing several biological samples, including tumors. For instance, OrganoidBase (developed by Crown Bioscience) consists of 342 tumor organoid models derived from patient-derived xenograft (PDX) models [i.e., PDX-derived organoids (PDXOs)]. PDXOs offer detailed information on histopathology, IC50, genomic, and transcriptomic analysis data associated with drug response; it also has an additional 217 models from primary patient samples. These PDXO models have varied indications, with multiple models derived from over 20 organ and tissue types. Crown Biosciences commercializes organoids in a 3D in vitro model derived using IP-protected Hubrecht Organoid Technology (HUB) protocols. Thus, such innovations are driving the market growth.

On the contrary, issues related to incorporation of organoids into existing workflows hampers the Middle East & Africa organoids market.

Based on organ type, the Middle East & Africa organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held 23.1% share of Middle East & Africa organoids market in 2022, amassing US$ 15.33 million. It is projected to garner US$ 55.57 million by 2030 to expand at 17.5% CAGR during 2022–2030.

Based on application, the Middle East & Africa organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held 29.7% share of Middle East & Africa organoids market in 2022, amassing US$ 19.71 million. It is projected to garner US$ 76.19 million by 2030 to expand at 18.4% CAGR during 2022–2030.

Based on source, the Middle East & Africa organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held 72.0% share of Middle East & Africa organoids market in 2022, amassing US$ 47.84 million. It is projected to garner US$ 182.28 million by 2030 to expand at 18.2% CAGR during 2022–2030.

Based on type, the Middle East & Africa organoids market is segmented into instruments, consumables, and services. The consumables segment held 57.6% share of Middle East & Africa organoids market in 2022, amassing US$ 38.26 million. It is projected to garner US$ 148.27 million by 2030 to expand at 18.5% CAGR during 2022–2030.

Based on country, the Middle East & Africa organoids market has been categorized into the South Africa, Saudi Arabia, UAE, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 36.7% share of Middle East & Africa organoids market in 2022. It was assessed at US$ 24.40 million in 2022 and is likely to hit US$ 83.32 million by 2030, exhibiting a CAGR of 16.6% during 2022–2030.

Key players operating in the Middle East & Africa organoids market are Cellesce, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc, among others.

In Aug 2021, InSphero AG announced that it is making its proprietary, patented 96- and 384-microwell plates available to researchers, enabling them to access the same plate technology used in the company’s flagship, assay-ready 3D InSight Human Liver Microtissues. The plates, engineered specifically for 3D cultures of spheroids and organoids, are available via InSphero’s online R&D Solutions Store.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa ANSI Cartridge Seals Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa
4.3 Ecosystem Analysis
4.4 Expert Opinions
5. Middle East & Africa ANSI Cartridge Seals Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Adoption in the Chemical & Petrochemical Industry
5.1.2 Increasing Strategic Initiatives from Manufacturers to Expand Production
5.2 Market Restraint
5.2.1 High Initial Costs and Availability of Alternative Mechanical Seals
5.3 Market Opportunities
5.3.1 Rising Demand for High Ambient Temperature Applications
5.4 Future Trends
5.4.1 Technological Advancements in Sealing Solutions and Pumps
5.5 Impact Analysis of Drivers And Restraints
6. ANSI Cartridge Seals – Middle East & Africa Market Analysis
6.1 Middle East & Africa ANSI Cartridge Seals Market Overview
6.2 Middle East & Africa ANSI Cartridge Seals Market Revenue Forecast and Analysis
7. Middle East & Africa ANSI Cartridge Seals Market – by Type
7.1 Overview
7.2 ANSI Cartridge Seals Market, by Type (2022 and 2030)
7.2.1 Single Cartridge Seals
7.2.1.1 Overview
7.2.1.2 Single Cartridge Seals: ANSI Cartridge Seals Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2 Dual Cartridge Seals
7.2.2.1 Overview
7.2.2.2 Dual Cartridge Seals: ANSI Cartridge Seals Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa ANSI Cartridge Seals Market – by Application
8.1 Overview
8.2 Cartridge Seals Market, by Application (2022 and 2030)
8.2.1 Chemical and Petrochemical Industry
8.2.1.1 Overview
8.2.1.2 Chemical and Petrochemical Industry: Cartridge Seals Market – Revenue and Forecast to 2030 (US$ Million)
8.2.2 Pharmaceutical Industry
8.2.2.1 Overview
8.2.2.2 Pharmaceutical Industry: Cartridge Seals Market – Revenue and Forecast to 2030 (US$ Million)
8.2.3 Food and Beverage Industry
8.2.3.1 Overview
8.2.3.2 Food and Beverage Industry: Cartridge Seals Market – Revenue and Forecast to 2030 (US$ Million)
8.2.4 Others
8.2.4.1 Overview
8.2.4.2 Others: Cartridge Seals Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa ANSI Cartridge Seals Market – by Country Analysis
9.1 Middle East & Africa: ANSI cartridge seals Market
9.1.1 Middle East & Africa: ANSI cartridge seals Market, by Key Country
9.1.1.1 Saudi Arabia: ANSI Cartridge Seals Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.1 Saudi Arabia: ANSI Cartridge Seals Market, by Type
9.1.1.1.2 Saudi Arabia: ANSI Cartridge Seals Market, by Application
9.1.1.2 UAE: ANSI Cartridge Seals Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.1 UAE: ANSI Cartridge Seals Market, by Type
9.1.1.2.2 UAE: ANSI Cartridge Seals Market, by Application
9.1.1.3 South Africa: ANSI Cartridge Seals Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 South Africa: ANSI Cartridge Seals Market, by Type
9.1.1.3.2 South Africa: ANSI Cartridge Seals Market, by Application
9.1.1.4 Rest of Middle East & Africa: ANSI Cartridge Seals Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.1 Rest of MEA: ANSI Cartridge Seals Market, by Type
9.1.1.4.2 Rest of Middle East & Africa: ANSI Cartridge Seals Market, by Application
10. Industry Landscape
10.1 Overview
10.2 Market Initiative
10.3 Product Development
10.4 Mergers & Acquisitions
11. Company Profiles
11.1 A W Chesterton Co
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 AESSEAL Plc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 HI-FAB Engineers Pvt Ltd
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Scenic Co Ltd
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Flowserve Corp
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 EagleBurgmann Germany GmbH & Co KG
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Flexaseal Engineered Seals and Systems LLC
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About
12.2 Word Index

LIST OF TABLES

Table 1. Middle East & Africa Organoids Market Segmentation
Table 2. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 3. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 4. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 5. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 6. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 7. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 8. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 9. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 10. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 11. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 12. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 13. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 14. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 15. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 16. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 17. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 18. Organic Developments Done by Companies
Table 19. Inorganic Developments Done by Companies
Table 20. Glossary of Terms, Middle East & Africa Organoids Market

LIST OF FIGURES

Figure 1. Middle East & Africa Organoids Market Segmentation, By Country
Figure 2. Middle East & Africa – PEST Analysis
Figure 3. Middle East & Africa Organoids Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Middle East & Africa Organoids Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Middle East & Africa Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
Figure 7. Stomach: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Intestine: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Liver: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Pancreas: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Lung: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Brain: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Kidney: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Middle East & Africa Organoids Market Revenue Share, by Application 2022 & 2030 (%)
Figure 16. Developmental Biology: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Disease Pathology of Infectious Disease: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Regenerative Medicine: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Drug Toxicity and Efficacy Testing: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Drug Discovery and Personalized Medicine: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Middle East & Africa Organoids Market Revenue Share, by Source 2022 & 2030 (%)
Figure 23. Pluripotent Stem Cells: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Organ-specific Adult Stem Cells: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Middle East & Africa Organoids Market Revenue Share, by Type 2022 & 2030 (%)
Figure 26. Instruments: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Consumables: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Services: Middle East & Africa Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Organoids Market, By Geography, 2022 And 2030 ($Mn)
Figure 30. Middle East & Africa Organoids Market, By Key Countries, 2022 And 2030 (%)
Figure 31. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Pre & Post COVID-19 Impact
Figure 36. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies – Middle East & Africa Organoids Market

– Cellesce
– InSphero
– Merck KGaA
– STEMCELL Technologies Inc
– Thermo Fisher Scientific Inc

Reviews

There are no reviews yet.

Be the first to review “Middle East & Africa Organoids Market Forecast to 2030”